Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo de revisión (ReviewArticle)

Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021

  • Vogel, Nina
  • Schmidt, Phillipp
  • Lange, Rosa
  • Gerofke, Antje
  • Sakhi, Amrit K
  • Haug, Line S
  • Jensen, Tina Kold
  • Frederiksen, Hanne
  • Szigeti, Tamás
  • Csákó, Zsófia
  • Palkovicova Murinova, Lubica
  • Šidlovská, Miroslava
  • Janasik, Beata
  • Wasowicz, Wojciech
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Barbone, Fabio
  • Rosolen, Valentina
  • Rambaud, Loïc
  • Riou, Margaux
  • Murawski, Aline
  • Leseman, Daan
  • Koppen, Gudrun
  • Covaci, Adrian
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Zvonař, Martin
  • Andryskova, Lenka
  • Fábelová, Lucia
  • Richterová, Denisa
  • Horvat, Milena
  • Kosjek, Tina
  • Sarigiannis, Denis
  • Maroulis, Marios
  • Pedraza-Diaz, Susana
  • Cañas Portilla, Ana Isabel
  • Verheyen, Veerle J
  • Bastiaensen, Michiel
  • Gilles, Liese
  • Schoeters, Greet
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Govarts, Eva
  • Koch, Holger M
  • Kolossa-Gehring, Marike
Phthalates are mainly used as plasticizers for polyvinyl chloride (PVC). Exposure to several phthalates is associated with different adverse effects most prominently on the development of reproductive functions. The HBM4EU Aligned Studies (2014-2021) have investigated current European exposure to ten phthalates (DEP, BBzP, DiBP, DnBP, DCHP, DnPeP, DEHP, DiNP, DiDP, DnOP) and the substitute DINCH to answer the open policy relevant questions which were defined by HBM4EU partner countries and EU institutions as the starting point of the programme. The exposure dataset includes ∼5,600 children (6-11 years) and adolescents (12-18 years) from up to 12 countries per age group and covering the North, East, South and West European regions. Study data from participating studies were harmonised with respect to sample size and selection of participants, selection of biomarkers, and quality and comparability of analytical results to provide a comparable perspective of European exposure. Phthalate and DINCH exposure were deduced from urinary excretions of metabolites, where concentrations were expressed as their key descriptor geometric mean (GM) and 95th percentile (P95). This study aims at reporting current exposure levels and differences in these between European studies and regions, as well as comparisons to human biomonitoring guidance values (HBM-GVs). GMs for children were highest for ∑DEHP metabolites (33.6 μg/L), MiBP (26.6 μg/L), and MEP (24.4 μg/L) and lowest for∑DiDP metabolites (1.91 μg/L) and ∑DINCH metabolites (3.57 μg/L). In adolescents highest GMs were found for MEP (43.3 μg/L), ∑DEHP metabolites (28.8 μg/L), and MiBP (25.6 μg/L) and lowest for ∑DiDP metabolites (= 2.02 μg/L) and ∑DINCH metabolites (2.51 μg/L). In addition, GMs and P95 stratified by European region, sex, household education level, and degree of urbanization are presented. Differences in average biomarker concentrations between sampling sites (data collections) ranged from factor 2 to 9. Compared to the European average, children in the sampling sites OCC (Denmark), InAirQ (Hungary), and SPECIMEn (The Netherlands) had the lowest concentrations across all metabolites and ESTEBAN (France), NAC II (Italy), and CROME (Greece) the highest. For adolescents, comparably higher metabolite concentrations were found in NEB II (Norway), PCB cohort (Slovakia), and ESTEBAN (France), and lower concentrations in POLAES (Poland), FLEHS IV (Belgium), and GerES V-sub (Germany). Multivariate analyses (Survey Generalized Linear Models) indicate compound-specific differences in average metabolite concentrations between the four European regions. Comparison of individual levels with HBM-GVs revealed highest rates of exceedances for DnBP and DiBP, with up to 3 and 5%, respectively, in children and adolescents. No exceedances were observed for DEP and DINCH. With our results we provide current, detailed, and comparable data on exposure to phthalates in children and - for the first time - in adolescents, and - for the first time - on DINCH in children and adolescents of all four regions of Europe which are particularly suited to inform exposure and risk assessment and answer open policy relevant questions.
Repisalud
Publication Artículo de revisión (ReviewArticle)

Exposure to flame retardants in European children - Results from the HBM4EU aligned studies

  • van der Schyff, Veronica
  • Kalina, Jiři
  • Govarts, Eva
  • Gilles, Liese
  • Schoeters, Greet
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Kohoutek, Jiří
  • Kukučka, Petr
  • Covaci, Adrian
  • Koppen, Gudrun
  • Andrýsková, Lenka
  • Piler, Pavel
  • Klánová, Jana
  • Jensen, Tina Kold
  • Rambaud, Loïc
  • Riou, Margaux
  • Lamoree, Marja
  • Kolossa-Gehring, Marike
  • Vogel, Nina
  • Weber, Till
  • Göen, Thomas
  • Gabriel, Catherine
  • Sarigiannis, Dimosthenis A
  • Sakhi, Amrit Kaur
  • Haug, Line Småstuen
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Melymuk, Lisa
Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.
Repisalud
Publication Artículo de revisión (ReviewArticle)

Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021)

  • Govarts, Eva
  • Gilles, Liese
  • Rodriguez Martin, Laura
  • Santonen, Tiina
  • Apel, Petra
  • Alvito, Paula
  • Anastasi, Elena
  • Andersen, Helle Raun
  • Andersson, Anna-Maria
  • Andryskova, Lenka
  • Antignac, Jean-Philippe
  • Appenzeller, Brice
  • Barbone, Fabio
  • Barnett-Itzhaki, Zohar
  • Barouki, Robert
  • Berman, Tamar
  • Bil, Wieneke
  • Borges, Teresa
  • Buekers, Jurgen
  • Cañas Portilla, Ana Isabel
  • Covaci, Adrian
  • Csákó, Zsófia
  • Den Hond, Elly
  • Dvorakova, Darina
  • Fábelová, Lucia
  • Fletcher, Tony
  • Frederiksen, Hanne
  • Gabriel, Catherine
  • Ganzleben, Catherine
  • Göen, Thomas
  • Halldórsson, Thórhallur Ingi
  • Haug, Line S
  • Horvat, Milena
  • Huuskonen, Pasi
  • Imboden, Medea
  • Jagodic Hudobivnik, Marta
  • Janasik, Beata
  • Janev Holcer, Natasa
  • Karakitsios, Spyros
  • Katsonouri, Andromachi
  • Klánová, Jana
  • Kokaraki, Venetia
  • Kold Jensen, Tina
  • Koponen, Jani
  • Laeremans, Michelle
  • Laguzzi, Federica
  • Lange, Rosa
  • Lemke, Nora
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Lobo Vicente, Joana
  • Luijten, Mirjam
  • Makris, Konstantinos C
  • Mazej, Darja
  • Melymuk, Lisa
  • Meslin, Matthieu
  • Mol, Hans
  • Montazeri, Parisa
  • Murawski, Aline
  • Namorado, Sónia
  • Niemann, Lars
  • Nübler, Stefanie
  • Nunes, Baltazar
  • Ólafsdóttir, Kristin
  • Palkovicova Murinova, Lubica
  • Papaioannou, Nafsika
  • Pedraza-Diaz, Susana
  • Piler, Pavel
  • Plichta, Veronika
  • Poteser, Michael
  • Probst-Hensch, Nicole
  • Rambaud, Loïc
  • Rauscher-Gabernig, Elke
  • Rausova, Katarina
  • Remy, Sylvie
  • Riou, Margaux
  • Rosolen, Valentina
  • Rousselle, Christophe
  • Rüther, Maria
  • Sarigiannis, Denis
  • Silva, Maria J
  • Šlejkovec, Zdenka
  • Snoj Tratnik, Janja
  • Stajnko, Anja
  • Szigeti, Tamás
  • Tarazona, Jose
  • Thomsen, Cathrine
  • Tkalec, Žiga
  • Tolonen, Hanna
  • Trnovec, Tomas
  • Uhl, Maria
  • Van Nieuwenhuyse, An
  • Vasco, Elsa
  • Verheyen, Veerle J
  • Viegas, Susana
  • Vinggaard, Anne Marie
  • Vogel, Nina
  • Vorkamp, Katrin
  • Wasowicz, Wojciech
  • Weber, Till
  • Wimmerova, Sona
  • Woutersen, Marjolijn
  • Zimmermann, Philipp
  • Zvonař, Martin
  • Koch, Holger M
  • Kolossa-Gehring, Marike
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Stewart, Lorraine
  • Sepai, Ovnair
  • Schoeters, Greet
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures.
Repisalud
Publication Artículo de revisión (ReviewArticle)

A step towards harmonising human biomonitoring study setup on European level: Materials provided and lessons learnt in HBM4EU

  • Pack, L Kim
  • Gilles, Liese
  • Cops, Jirka
  • Tolonen, Hanna
  • van Kamp, Irene
  • Esteban-Lopez, Marta
  • Pedraza-Diaz, Susana
  • Lacasaña, Marina
  • González Alzaga, Beatríz
  • Lermen, Dominik
  • Bartel-Steinbach, Martina
  • Katsonouri, Andromachi
  • Fiddicke, Ulrike
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
Internal exposure of the human body to potentially harmful chemical substances can be assessed by Human Biomonitoring (HBM). HBM can be used to generate conclusive data that may provide an overview of exposure levels in entire or specific population groups. This knowledge can promote the understanding of potential risks of the substances of interest or help monitoring the success of regulatory measures taken on the political level. Study planning and design are key elements of any epidemiologic study to generate reliable data. In the field of HBM, this has been done using differing approaches on various levels of population coverage so far. Comparison and combined usage of the resulting data would contribute to understanding exposure and its factors on a larger scale, however, the differences between studies make this a challenging and somewhat limited endeavour. This article presents templates for documents that are required to set up an HBM study, thus facilitating the generation of harmonised HBM data as a step towards standardisation of HBM in Europe. They are designed to be modular and adaptable to the specific needs of a single study while emphasising minimum requirements to ensure comparability. It further elaborates on the challenges encountered during the process of creating these documents during the runtime of the European Joint Programme HBM4EU in a multi-national expert team and draws up lessons learnt in the context of knowledge management.
Repisalud
Publication Artículo de revisión (ReviewArticle)

Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU

  • Gerofke, Antje
  • Lange, Rosa
  • Vogel, Nina
  • Schmidt, Phillipp
  • Weber, Till
  • David, Madlen
  • Frederiksen, Hanne
  • Baken, Kirsten
  • Govarts, Eva
  • Gilles, Liese
  • Rodriguez Martin, Laura
  • Martinsone, Žanna
  • Santonen, Tiina
  • Schoeters, Greet
  • Scheringer, Martin
  • Domínguez-Romero, Elena
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Koch, Holger M
  • Apel, Petra
  • Kolossa-Gehring, Marike
Phthalates and the substitute plasticizer DINCH belong to the first group of priority substances investigated by the European Human Biomonitoring Initiative (HBM4EU) to answer policy-relevant questions and safeguard an efficient science-to-policy transfer of results. Human internal exposure levels were assessed using two data sets from all European regions and Israel. The first collated existing human biomonitoring (HBM) data (2005-2019). The second consisted of new data generated in the harmonized "HBM4EU Aligned Studies" (2014-2021) on children and teenagers for the ten most relevant phthalates and DINCH, accompanied by a quality assurance/quality control (QA/QC) program for 17 urinary exposure biomarkers. Exposures differed between countries, European regions, age groups and educational levels. Toxicologically derived Human biomonitoring guidance values (HBM-GVs) were exceeded in up to 5% of the participants of the HBM4EU Aligned Studies. A mixture risk assessment (MRA) including five reprotoxic phthalates (DEHP, DnBP, DiBP, BBzP, DiNP) revealed that for about 17% of the children and teenagers, health risks cannot be excluded. Concern about male reproductive health emphasized the need to include other anti-androgenic substances for MRA. Contaminated food and the use of personal care products were identified as relevant exposure determinants paving the way for new regulatory measures. Time trend analyses verified the efficacy of regulations: especially for the highly regulated phthalates exposure dropped significantly, while levels of the substitutes DINCH and DEHTP increased. The HBM4EU e-waste study, however, suggests that workers involved in e-waste management may be exposed to higher levels of restricted phthalates. Exposure-effect association studies indicated the relevance of a range of endpoints. A set of HBM indicators was derived to facilitate and accelerate science-to-policy transfer. Result indicators allow different groups and regions to be easily compared. Impact indicators allow health risks to be directly interpreted. The presented results enable successful science-to-policy transfer and support timely and targeted policy measures.
Repisalud
Publication Artículo de revisión (ReviewArticle)

HBM4EU-MOM: Prenatal methylmercury-exposure control in five countries through suitable dietary advice for pregnancy - Study design and characteristics of participants

  • Katsonouri, Andromachi
  • Gabriel, Catherine
  • Esteban-Lopez, Marta
  • Namorado, Sónia
  • Halldórsson, Thórhallur Ingi
  • Snoj Tratnik, Janja
  • Rodriguez Martin, Laura
  • Karakoltzidis, Achilleas
  • Chatzimpaloglou, Anthoula
  • Giannadaki, Despina
  • Anastasi, Elena
  • Thoma, Anthi
  • Domínguez-Morueco, Noelia
  • Cañas Portilla, Ana Isabel
  • Jacobsen, Eva
  • Assunção, Ricardo
  • Peres, Maria
  • Santiago, Susana
  • Nunes, Carla
  • Pedraza-Diaz, Susana
  • Iavicoli, Ivo
  • Leso, Veruscka
  • Lacasaña, Marina
  • González-Alzaga, Beatriz
  • Horvat, Milena
  • Sepai, Ovnair
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
  • Karakitsios, Spyros
  • Sarigiannis, Dimosthenis
Background: Seafood is a major source of vital nutrients for optimal fetal growth, but at the same time is the main source of exposure to methylmercury (MeHg), an established neurodevelopmental toxicant. Pregnant women must be provided with dietary advice so as to include safely fish in their diet for nutrition and mercury control. The aim of this work is to present the design of a multicentre randomized control trial (RCT), which combines human biomonitoring (HBM) with dietary interventions using seafood consumption advice to pregnant women for MeHg control, and to collect information about other possible sources of exposure to mercury. It also presents the materials developed for the implementation of the study and the characteristics of the study participants, which were self-reported in the first trimester of pregnancy. Methods: The "HBM4EU-MOM" RCT was performed in the frame of the European Human Biomonitoring Initiative (HBM4EU) in five coastal, high fish-consuming European countries (Cyprus, Greece, Spain, Portugal and Iceland). According to the study design, pregnant women (≥120/country, ≤20 weeks gestational age) provided a hair sample for total mercury assessment (THg) and personal information relevant to the study (e.g., lifestyle, pregnancy status, diet before and during the pregnancy, information on seafood and factors related to possible non-dietary exposures to mercury) during the first trimester of pregnancy. After sampling, participants were randomly assigned to "control" (habitual practices) or "intervention" (received the harmonized HBM4EU-MOM dietary advice for fish consumption during the pregnancy and were encouraged to follow it). Around child delivery, participants provided a second hair sample and completed another tailored questionnaire. Results: A total of 654 women aged 18-45 years were recruited in 2021 in the five countries, primarily through their health-care providers. The pre-pregnancy BMI of the participants ranged from underweight to obese, but was on average within the healthy range. For 73% of the women, the pregnancy was planned. 26% of the women were active smokers before the pregnancy and 8% continued to smoke during the pregnancy, while 33% were passive smokers before pregnancy and 23% remained passively exposed during the pregnancy. 53% of the women self-reported making dietary changes for their pregnancy, with 74% of these women reporting making the changes upon learning of their pregnancy. Of the 43% who did not change their diet for the pregnancy, 74% reported that their diet was already balanced, 6% found it difficult to make changes and 2% were unsure of what changes to make. Seafood consumption did not change significantly before and during the first trimester of pregnancy (overall average ∼8 times per month), with the highest frequency reported in Portugal (≥15 times per month), followed by Spain (≥7 times per month). During the first-trimester of pregnancy, 89% of the Portuguese women, 85% of the Spanish women and <50% of Greek, Cypriot and Icelandic women reported that they had consumed big oily fish. Relevant to non-dietary exposure sources, most participants (>90%) were unaware of safe procedures for handling spillage from broken thermometers and energy-saving lamps, though >22% experienced such an incident (>1 year ago). 26% of the women had dental amalgams. ∼1% had amalgams placed and ∼2% had amalgams removed during peri-pregnancy. 28% had their hair dyed in the past 3 months and 40% had body tattoos. 8% engaged with gardening involving fertilizers/pesticides and 19% with hobbies involving paints/pigments/dyes. Conclusions: The study design materials were fit for the purposes of harmonization and quality-assurance. The harmonized information collected from pregnant women suggests that it is important to raise the awareness of women of reproductive age and pregnant women about how to safely include fish in their diet and to empower them to make proper decisions for nutrition and control of MeHg, as well as other chemical exposures.
Repisalud
Publication Artículo de revisión (ReviewArticle)

Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt

  • Vorkamp, Katrin
  • Esteban-Lopez, Marta
  • Gilles, Liese
  • Göen, Thomas
  • Govarts, Eva
  • Hajeb, Parvaneh
  • Katsonouri, Andromachi
  • Knudsen, Lisbeth E
  • Kolossa-Gehring, Marike
  • Lindh, Christian
  • Nübler, Stefanie
  • Pedraza-Diaz, Susana
  • Santonen, Tiina
  • Castaño, Argelia
The European Human Biomonitoring Initiative (HBM4EU) ran from 2017 to 2022 with the aim of advancing and harmonizing human biomonitoring in Europe. More than 40,000 analyses were performed on human samples in different human biomonitoring studies in HBM4EU, addressing the chemical exposure of the general population, temporal developments, occupational exposure and a public health intervention on mercury in populations with high fish consumption. The analyses covered 15 priority groups of organic chemicals and metals and were carried out by a network of laboratories meeting the requirements of a comprehensive quality assurance and control system. The coordination of the chemical analyses included establishing contacts between sample owners and qualified laboratories and monitoring the progress of the chemical analyses during the analytical phase, also addressing status and consequences of Covid-19 measures. Other challenges were related to the novelty and complexity of HBM4EU, including administrative and financial matters and implementation of standardized procedures. Many individual contacts were necessary in the initial phase of HBM4EU. However, there is a potential to develop more streamlined and standardized communication and coordination in the analytical phase of a consolidated European HBM programme.